ICOSLG and melanoma: We observed higher proportions of circulating iNKT cells expressing ICOSL, PD-L2 (Figure 3D), ICOS, TIM3 (Figure 3E), and 4-1BB (Supplementary Figure S2D) in melanoma patients compared with HDs.